{
  "id": "cluster_13_docid4",
  "content": "Policy update RV-2023-45 revision 3 expands biologic therapy coverage for members enrolled in qualifying clinical trials. Effective 9/1/2023, prior authorization waivers apply when studies meet NIH registry standards. Implementation note: Mountain View Specialty Clinic has 12 active patients affected, including 5 dual-diagnosis cases.",
  "metadata": {
    "format": "policy_document"
  }
}